TB-500 healing claims often rely on tests of thymosin beta-4.
Researchers copied a protein stretch to make TB-500 and study how cells reach wounds. Most later healing tests gave the source protein, leaving your treatment questions unanswered.
TB-500 copies a short stretch of a much longer protein
Thymosin beta-4 is a protein in your body, made of forty-three linked parts. Researchers copied seven of those parts when they made TB-500 for study.
The copied stretch holds a protein called actin, which cells need for movement [5]. Moving cells can reach a wound and help repair the damaged skin.
That role led researchers to study healing, but mostly with thymosin beta-4 [5]. Giving the longer protein doesn't show what happens when someone receives TB-500.
Names can hide that difference when you read a treatment claim. A seller may say TB-500 while pointing to findings about the longer protein.
TB-500 weighs about 889 daltons, a unit used for weighing tiny proteins. The longer thymosin beta-4 weighs about 4963 daltons, reflecting the parts left out.
Research supplies are sold, but TB-500 has no approved use for treating illness. Sports rules prohibit the copied chain, and FDA raised pharmacy safety concerns in 2023.
Someone later ended the request to allow pharmacies to use the copied chain. Ending that request didn't grant approval; the pharmacy rules explain the questions that remain.
Your health question includes whether encouraging new growth might also help cancer grow. The cancer findings explain why that concern hasn't been settled in people.
The cell movement findings show why the early research drew interest. Before judging a claim, you need findings about the treatment being offered.
TB-500 cannot release thymosin beta-4’s part linked to less scarring
TB-500 consists of linked protein parts in a short chain, called a peptide [1]. Your cells use actin to move and change shape; the copied stretch holds actin.
Researchers examined that hold using an X-ray of proteins prepared for laboratory study. They attached part of another protein to thymosin beta-4 to examine the hold.
The protein X-ray showed details 2 angstroms apart, an extremely small distance. Researchers were examining joined proteins; no patient's injury was being X-rayed.
The hold was 1:1, with one thymosin beta-4 attached to one actin [1]. Covering actin's ends kept spare actin from joining other actin pieces into long strands.
Cells use those strands for movement, but also need spare pieces ready. Holding spare actin apart keeps a reserve for cells to use when needed.
Research bottles hold dried powder that hasn't been approved for your treatment. Laboratory workers add sterile water, which is germ-free, or water that limits germ growth.
The shorter chain withstands storage better, although the contents can deteriorate after being frozen and thawed several times [5]. Your body also breaks down protein chains after you receive the substance.
A research label doesn't assure you that the bottle holds the shorter chain. Some bottles may hold thymosin beta-4, so a reported change might concern another substance.
Breaking down the longer protein releases a separate part linked to less scarring. TB-500 lacks the end that supplies that part, so the copied chain can't release it [5].
Thymosin beta-4 released near injuries underlies many TB-500 claims
Nearly every cell contains thymosin beta-4, a protein made of forty-three linked parts [5]. Cells involved in blood clotting and fighting germs release thymosin beta-4 near wounds.
Thymosin beta-4 holds spare actin for the changes in shape that allow your cells to move [1][5]. That reserve keeps pieces available as a cell builds the strands needed for movement.
In injury experiments, cells moved toward damage sooner and new blood vessels appeared [5]. Fewer cells died, less scar tissue formed, and inflammation was reduced.
Inflammation follows your body's response to an injury and can bring painful, warm swelling. Researchers then studied skin wounds, damaged eyes, and injured hearts in people.
Those repair findings mostly concern the longer protein, though sellers may call them TB-500 evidence [5]. You still need to know whether TB-500 produces useful healing.
Retaining the actin-holding stretch doesn't preserve every part of the longer protein. The healing studies explain why the results leave your TB-500 questions open.
Healthy volunteers received the longer protein in the early safety study
A finished trial hasn't compared TB-500 treatment with other care in people [5]. The human safety findings concern thymosin beta-4 delivered through a vein.
In Phase 1, the study was an early test looking mainly for harm. The 40 healthy volunteers were divided into four groups of 10.
Each group tested a different amount, with some volunteers receiving a placebo containing no studied protein. A placebo allows researchers to compare treatment with a similar treatment lacking the protein.
The groups tested 42, 140, 420, or 1260 milligrams of thymosin beta-4. After the initial treatment, each group received treatment daily for 14 days [6].
Few unwanted effects occurred, and none was worse than moderate in severity. No serious harm or effects requiring lower treatment amounts were reported.
Higher amounts led to higher blood levels, in line with researchers' expectations. That finding didn't establish better healing for people with an injury.
You can't use those amounts as a tested plan for TB-500. The study didn't test TB-500 shots placed within muscle or beneath skin.
High thymosin beta-4 levels in several cancers are associated with cancers that spread [7][8]. Cell movement and added blood vessels could, in theory, help a tumor grow [7].
The TB-500 side effects explain that concern and the missing human answers. The pharmacy rules address a separate question about preparing medicine for your prescription.
You can also read answers about treatment claims before judging a claim. This study's safety finding belongs to the longer protein, leaving the copied chain's risks unanswered.
TB-500 skin hopes rest on thymosin beta-4 given to rats
Researchers studied thymosin beta-4 for skin, brain, heart, and hair changes [5]. Thymosin beta-4 work mainly tested animals or cells in laboratory dishes.
In rats with deep wounds, covering skin increased 42% after 4 days. Growth was up to 61% greater after 7 days than with salt-water treatment.
Wounds narrowed, while more vessels and collagen formed; collagen gives skin strength. Skin cells in dishes moved two- to three-fold more with 10 picograms of treatment [3].
A picogram weighs a trillionth of a gram, so that amount was tiny. A finding in a dish doesn't set a safe treatment amount for you.
Mice missing a muscle protein received 150 micrograms twice weekly for 6 months. A gram contains a million micrograms; the treatment was thymosin beta-4.
The mice received shots inside the belly, into the space surrounding their organs. Those shots reached beyond the skin and muscle, unlike many shots people describe.
More muscle fibers formed, but the treated mice gained no strength [9]. Heart pumping and scarring didn't improve either, showing that growth alone may not restore function.
Changes reported after use do not establish what caused them
The personal reports describe what people noticed while trying TB-500 research supplies themselves. No comparison trial checked those experiences, leaving you without proof of what caused the changes; most healing studies gave thymosin beta-4.